1. Impact of dexamethasone on cardiac injury in critically ill COVID-19 patients. (3rd October 2022) Authors: Van Almsick, V; Jirak, P; Dimitroulis, D; Mirna, M; Seelmaier, C; Shomanova, Z; Semo, D; Dankl, D; Mahringer, M; Lichtenauer, M; Hoppe, U; Reinecke, H; Larbig, R; Motloch, L; Pistulli, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Dexamethasone improves cardiovascular outcomes in critically ill COVID-19, a real world scenario multicenter analysis. (3rd October 2022) Authors: Jirak, P; Van Almsick, V; Dimitroulis, D; Mirna, M; Seelmaier, C; Shomanova, Z; Semo, D; Dankl, D; Mahringer, M; Lichtenauer, M; Hoppe, U; Reinecke, H; Pistulli, R; Larbig, R; Motloch, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary human monocytes are stimulated in a pro-atherosclerotic manner in hyperhomocysteine conditions by attenuated PTEN phosphatase function. (3rd October 2022) Authors: Dorenkamp, M; Semo, D; Miao, L; Koch, S; Reinecke, H; Godfrey, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inflammatory and diabetic conditions trigger SHP2 tyrosine phosphatase expression and subsequent aberrant activation of primary human monocytes. (3rd October 2022) Authors: Dorenkamp, M; Nasiry, M; Koch, S; Semo, D; Loeffler, I; Wolf, G; Reinecke, H; Godfrey, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Analysis of novel cardiac biomarkers in diagnosis of decompensated heart failure. (3rd October 2022) Authors: Froehling, T; Mirna, M; Paar, V; Shomanova, Z; Van Almsick, V; J Motloch, L; Semo, D; Makowski, L; Rukosujew, A; Sindermann, J R; Reinecke, H; Lichtenauer, M; Pistulli, R Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Monocyte and endothelial dysfunction induced by hyperglycemia is reversed by Empagliflozin mainly through glucose-transport independent mechanisms. (3rd October 2022) Authors: Semo, D; Obergassel, J; Dorenkamp, M; Godfrey, R; Waltenberger, J Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗